Neurology India
Open access journal indexed with Index Medicus
  Users online: 449  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed26511    
    Printed488    
    Emailed35    
    PDF Downloaded1542    
    Comments [Add]    
    Cited by others 26    

Recommend this journal

 

 REVIEW ARTICLE
Year : 2008  |  Volume : 56  |  Issue : 3  |  Page : 236--247

Duchenne muscular dystrophy


1 Children's Neuroscience Centre, Royal Children's Hospital Melbourne, Australia
2 Children's Neuroscience Centre, Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Department of Pediatrics University of Melbourne, Australia

Correspondence Address:
Andrew J Kornberg
Children's Neuroscience Centre, Royal Children's Hospital Melbourne, Flemington Road, Parkville, Victoria, 3052
Australia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.43441

Rights and Permissions

Duchenne muscular dystrophy (DMD), an X-linked disorder, is the most common muscular dystrophy in children, presenting in early childhood and characterized by proximal muscle weakness and calf hypertrophy in affected boys. Patients usually become wheelchair-bound by the age of 12 years, and die of cardiorespiratory complications in their late teens to early twenties. Advances in the management of DMD, including treatment with corticosteroids and the use of intermittent positive pressure ventilation have provided improvements in function, ambulation, quality of life and life expectancy, although novel therapies still aim to provide a cure for this devastating disorder. The clinical features, investigations, and management of DMD are reviewed, as well as the latest in some of the novel therapies.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow